FDA Approves Isatuximab On-Body Injector for Multiple Myeloma, Raising Anti-CD38 Competition
The FDA approved Sarclisa Escena, an on-body injector delivering isatuximab for multiple myeloma treatment, marking a first in anticancer therapy delivery.
Read More